Master patient flow analysis to predict pharma demand and provide better patient access.

16th June 2022
Key considerations for creating more accurate patient-based product forecasts.
Read More

Expert strategies to overcome the inherent inaccuracy of long range pharma forecasting

27th May 2022
Here we discuss why managing risk & opportunity is more important than accuracy when tackling your long range planning (LRP)
Read More

How J+D delivered a long-term forecasting model sooner than ever before using proprietary software tool

7th April 2022
J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
Read More

Big pharma boosts efficiency and gains a consistent forecasting approach with J+D’s FC365 platform

14th January 2022
J+D were approached by a global pharmaceutical company who needed a new forecasting solution with a robust process management system to give them a solid foundation when forecasting their pipeline assets. 
Read More

J+D helps pioneering biotech launch an efficient, best-practice forecasting process

21st October 2021
A clinical-stage biotech, with a broad oncology pipeline required an improved forecasting approach to support their launch strategy and pipeline prioritisation decision-making for a novel and innovative oncology technology.
Read More

How Microsoft Teams streamlined cross-country forecasting for biotech pioneers.

23rd April 2021
The background. In this case study, we showcase our latest work with one of Europe’s largest, leading biotechnology pioneers, helping to facilitate better, more collaborative forecasting for hundreds of colleagues across the continent. For the company’s most recent forecasting cycle, our experts have worked to…
Read More

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market

12th August 2020
The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a single line of treatment (for example,…
Read More

J+D Forecasting Changed the Forecasting Approach of a Global Biotech Forever

23rd July 2020
One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.
Read More